[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @tom_the_bomb__ ⛏🅾️Ⓜ️💣 ⛏🅾️Ⓜ️💣 posts on X about money, vertical, $pfe, $43b the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1293311479693934594/interactions)  - X Week XXXXXX -XX% - X Month XXXXXX +47% - X Months XXXXXXX -XX% - X Year XXXXXXX -XX% ### Mentions: XX [#](/creator/twitter::1293311479693934594/posts_active)  - X Week XX +20% - X Month XX +85% - X Months XXX -XXXX% - X Year XXX +0.25% ### Followers: XXXXX [#](/creator/twitter::1293311479693934594/followers)  - X Week XXXXX +0.15% - X Month XXXXX +0.30% - X Months XXXXX +1.30% - X Year XXXXX +1.80% ### CreatorRank: XXXXXXX [#](/creator/twitter::1293311479693934594/influencer_rank)  ### Social Influence [#](/creator/twitter::1293311479693934594/influence) --- **Social category influence** [stocks](/list/stocks) XXX% [finance](/list/finance) XXX% [currencies](/list/currencies) XXX% **Social topic influence** [money](/topic/money) 0.7%, [vertical](/topic/vertical) 0.7%, [$pfe](/topic/$pfe) 0.7%, [$43b](/topic/$43b) 0.7%, [$azn](/topic/$azn) #8, [$dsnky](/topic/$dsnky) 0.7%, [$mrk](/topic/$mrk) 0.7%, [$991m](/topic/$991m) 0.7%, [eli lilly](/topic/eli-lilly) 0.7%, [faster](/topic/faster) XXX% **Top accounts mentioned or mentioned by** [@avacta](/creator/undefined) [@asininitybeyond](/creator/undefined) [@seandentbsc](/creator/undefined) [@bobdibble8](/creator/undefined) [@rah00084](/creator/undefined) [@andrewdigby3](/creator/undefined) [@neutroniclse](/creator/undefined) [@tragedycalls](/creator/undefined) [@towlie1981](/creator/undefined) [@jeskirrane](/creator/undefined) [@novartis](/creator/undefined) [@jstonker](/creator/undefined) [@esspekay](/creator/undefined) [@elilillyandco](/creator/undefined) [@tren116](/creator/undefined) [@mike182035](/creator/undefined) [@holmdene](/creator/undefined) [@111ben111](/creator/undefined) [@blueberrymgmnt](/creator/undefined) [@massivefannwo](/creator/undefined) **Top assets mentioned** [Pfizer, Inc. (PFE)](/topic/$pfe) [AstraZeneca PLC (AZN)](/topic/$azn) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Eli Lilly and Company (LLY)](/topic/eli-lilly) ### Top Social Posts [#](/creator/twitter::1293311479693934594/posts) --- Top posts by engagements in the last XX hours "@asininitybeyond @Towlie1981 @PJ_Crabb AI's view below. #AVCT" [X Link](https://x.com/tom_the_bomb__/status/1977655524507435158) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-13T08:39Z 3304 followers, 1964 engagements "@Jenkoool Huge amounts of money around for preclinical assets. Which is why I keep leaning towards a buyout sooner rather than later. Ample opportunity to sign multiple deals" [X Link](https://x.com/tom_the_bomb__/status/1978531050285343118) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-15T18:38Z 3305 followers, XXX engagements "@paddygall1 @shaun_day_ @GreatlandGold 8500oz per vertical metre" [X Link](https://x.com/tom_the_bomb__/status/1410887534935224323) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2021-07-02T09:06Z 3306 followers, XX engagements "I wonder what BP is saying about #AVCTs preCISION platform Pfizer: Buy once unlock Seagens entire ADC portfolio & finally dose TOP1 payloads without hitting toxicity walls. Turns a $43B Seagen buy into a platform that actually reaches its potential. 1/4 #AVCT $PFE" [X Link](https://x.com/tom_the_bomb__/status/1976221095448744158) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-09T09:40Z 3306 followers, 3156 engagements "AstraZeneca: Integrate preCISION to extend #Enhertus reach significantly improve dosing potential & move TOP1 chemistry into new tumour types. Frees them from dependency on $DSNKY and creates a next-gen deruxtecan. 2/4 #AVCT $AZN #AZN" [X Link](https://x.com/tom_the_bomb__/status/1976221097927618929) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-09T09:40Z 3306 followers, 1799 engagements "Merck: Combine tumour-activated chemo with #Keytruda to deliver unprecedented tumour clearance while preserving immune function. A whole new class: chemo-immunotherapy XXX. 4/4 #AVCT $MRK" [X Link](https://x.com/tom_the_bomb__/status/1976221104361570339) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-09T09:40Z 3306 followers, 3691 engagements "Boehringer Ingelheim advances ADC portfolio with an Exatecan-based ADC (AMB304) from AimedBio worth up to $991M. AMB304 is a preclinical asset. AimedBio have one asset in Phase X. #AVCT" [X Link](https://x.com/tom_the_bomb__/status/1978503158197363003) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-15T16:48Z 3306 followers, 3756 engagements "@SeanDentBsc @TragedyCalls So which will it be. Partnerships then a buyout makes the most sense (and definitely my preference before 6103 data)" [X Link](https://x.com/tom_the_bomb__/status/1978791015096971716) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-16T11:51Z 3306 followers, XXX engagements "@TBSfrench @AndrewDigby3 Not a shit week RH and his investors moved the SP north by fading the shadow of no cash Are you implying theres another placing on the way" [X Link](https://x.com/tom_the_bomb__/status/1979296878429938155) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-17T21:22Z 3306 followers, XX engagements "Eli Lilly: Leapfrog the ADC incumbents by pairing preCISION-exatecan with our bispecifics radiopharma & IO assets. Precision chemo without the ADC baggage = faster cleaner cheaper. 3/4 #AVCT $LLY" [X Link](https://x.com/tom_the_bomb__/status/1976221101555671408) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-09T09:40Z 3305 followers, 2778 engagements ""FAP-Dox and FAP-EXd are only the tip of the preCISION iceberg" Under the surface: "preCISION molecules in stages of preclinical testing and prep work for the clinic. Multiple therapeutic classes (n10)" Likely 11-15+ molecules across multiple therapeutic classes. #AVCT" [X Link](https://x.com/tom_the_bomb__/status/1977700069257183459) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-13T11:36Z 3305 followers, 2513 engagements "@asininitybeyond BIG update/insight from TD (IMO). A ATR or PARP inhibitor sits with the recent comments on an incoming pathway inhibitor deal. Few BP have both of these drug classes apart from AstraZeneca. #AVCT's dual-payload linker would solve AZs biggest limitation = overlapping toxicity" [X Link](https://x.com/tom_the_bomb__/status/1978101500623675553) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-14T14:12Z 3306 followers, 1710 engagements "@SeanDentBsc 6207 targets multi drug resistance + tumour heterogeneity. Im thinking something like exatecan + a second payload aimed at blocking DNA damage repair (a PARP inhibitor or a similar DNA repair pathway blocker). 6103 + 6207 is a PERFECT fit for AstraZeneca. #AVCT" [X Link](https://x.com/tom_the_bomb__/status/1979528973106208964) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-18T12:44Z 3308 followers, 3985 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@tom_the_bomb__ ⛏🅾️Ⓜ️💣
⛏🅾️Ⓜ️💣 posts on X about money, vertical, $pfe, $43b the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXX +47%
- X Months XXXXXXX -XX%
- X Year XXXXXXX -XX%
Mentions: XX #
- X Week XX +20%
- X Month XX +85%
- X Months XXX -XXXX%
- X Year XXX +0.25%
Followers: XXXXX #
- X Week XXXXX +0.15%
- X Month XXXXX +0.30%
- X Months XXXXX +1.30%
- X Year XXXXX +1.80%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XXX% finance XXX% currencies XXX%
Social topic influence money 0.7%, vertical 0.7%, $pfe 0.7%, $43b 0.7%, $azn #8, $dsnky 0.7%, $mrk 0.7%, $991m 0.7%, eli lilly 0.7%, faster XXX%
Top accounts mentioned or mentioned by @avacta @asininitybeyond @seandentbsc @bobdibble8 @rah00084 @andrewdigby3 @neutroniclse @tragedycalls @towlie1981 @jeskirrane @novartis @jstonker @esspekay @elilillyandco @tren116 @mike182035 @holmdene @111ben111 @blueberrymgmnt @massivefannwo
Top assets mentioned Pfizer, Inc. (PFE) AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK) Eli Lilly and Company (LLY)
Top Social Posts #
Top posts by engagements in the last XX hours
"@asininitybeyond @Towlie1981 @PJ_Crabb AI's view below. #AVCT"
X Link @tom_the_bomb__ 2025-10-13T08:39Z 3304 followers, 1964 engagements
"@Jenkoool Huge amounts of money around for preclinical assets. Which is why I keep leaning towards a buyout sooner rather than later. Ample opportunity to sign multiple deals"
X Link @tom_the_bomb__ 2025-10-15T18:38Z 3305 followers, XXX engagements
"@paddygall1 @shaun_day_ @GreatlandGold 8500oz per vertical metre"
X Link @tom_the_bomb__ 2021-07-02T09:06Z 3306 followers, XX engagements
"I wonder what BP is saying about #AVCTs preCISION platform Pfizer: Buy once unlock Seagens entire ADC portfolio & finally dose TOP1 payloads without hitting toxicity walls. Turns a $43B Seagen buy into a platform that actually reaches its potential. 1/4 #AVCT $PFE"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3306 followers, 3156 engagements
"AstraZeneca: Integrate preCISION to extend #Enhertus reach significantly improve dosing potential & move TOP1 chemistry into new tumour types. Frees them from dependency on $DSNKY and creates a next-gen deruxtecan. 2/4 #AVCT $AZN #AZN"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3306 followers, 1799 engagements
"Merck: Combine tumour-activated chemo with #Keytruda to deliver unprecedented tumour clearance while preserving immune function. A whole new class: chemo-immunotherapy XXX. 4/4 #AVCT $MRK"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3306 followers, 3691 engagements
"Boehringer Ingelheim advances ADC portfolio with an Exatecan-based ADC (AMB304) from AimedBio worth up to $991M. AMB304 is a preclinical asset. AimedBio have one asset in Phase X. #AVCT"
X Link @tom_the_bomb__ 2025-10-15T16:48Z 3306 followers, 3756 engagements
"@SeanDentBsc @TragedyCalls So which will it be. Partnerships then a buyout makes the most sense (and definitely my preference before 6103 data)"
X Link @tom_the_bomb__ 2025-10-16T11:51Z 3306 followers, XXX engagements
"@TBSfrench @AndrewDigby3 Not a shit week RH and his investors moved the SP north by fading the shadow of no cash Are you implying theres another placing on the way"
X Link @tom_the_bomb__ 2025-10-17T21:22Z 3306 followers, XX engagements
"Eli Lilly: Leapfrog the ADC incumbents by pairing preCISION-exatecan with our bispecifics radiopharma & IO assets. Precision chemo without the ADC baggage = faster cleaner cheaper. 3/4 #AVCT $LLY"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3305 followers, 2778 engagements
""FAP-Dox and FAP-EXd are only the tip of the preCISION iceberg" Under the surface: "preCISION molecules in stages of preclinical testing and prep work for the clinic. Multiple therapeutic classes (n10)" Likely 11-15+ molecules across multiple therapeutic classes. #AVCT"
X Link @tom_the_bomb__ 2025-10-13T11:36Z 3305 followers, 2513 engagements
"@asininitybeyond BIG update/insight from TD (IMO). A ATR or PARP inhibitor sits with the recent comments on an incoming pathway inhibitor deal. Few BP have both of these drug classes apart from AstraZeneca. #AVCT's dual-payload linker would solve AZs biggest limitation = overlapping toxicity"
X Link @tom_the_bomb__ 2025-10-14T14:12Z 3306 followers, 1710 engagements
"@SeanDentBsc 6207 targets multi drug resistance + tumour heterogeneity. Im thinking something like exatecan + a second payload aimed at blocking DNA damage repair (a PARP inhibitor or a similar DNA repair pathway blocker). 6103 + 6207 is a PERFECT fit for AstraZeneca. #AVCT"
X Link @tom_the_bomb__ 2025-10-18T12:44Z 3308 followers, 3985 engagements